A. Ernest WhitonChief Financial OfficerZOLL Medical Corporation+1 (978) 421-9655
Diane EganZOLL Medical Corporation+1 (978) firstname.lastname@example.org
FOR IMMEDIATE RELEASE
November 8, 2006—CHELMSFORD, MASS.—ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and related software solutions, today reported that Uintah Basin Medical Center (UBMC) is the first hospital in the state of Utah to deploy the ZOLL AutoPulse® Non-invasive Cardiac Support Pump. Based in Roosevelt, Utah (approximately 85 miles east of Provo), UBMC has deployed one AutoPulse in the hospital’s emergency department, which operates 24 hours a day, 7 days a week. Additionally, four AutoPulse devices are deployed on UBMC’s ambulance fleet, which serves more than 22,000 residents in a 3,200-square-mile area.
Commenting on the AutoPulse, UBMC’s EMT Director Von Johnson said, “Given we are in a rural area, having this kind of device that can do near-perfect CPR chest compressions is critical given the length of our transport times, which can be more than an hour. CPR performed using the AutoPulse is more consistent and efficient because it minimizes chest-compression interruptions and helps our medics in the field—and our clinicians in the ER—be able to do more for the patient. By having another rescuer available to help with life-saving interventions in lieu of doing manual chest compressions, we can provide better care for our cardiac arrest patients.”
The major emphasis of 2005 American Heart Association Guidelines is on performing effective, high-quality CPR. The 2005 Guidelines now recommend that when attempting defibrillation, rescuers should deliver 1 shock followed by immediate CPR, beginning with chest compressions for 2 minutes. Furthermore, the Guidelines note that the better the chest compressions performed (i.e., with adequate rate and depth and allowing complete chest recoil), the more blood flow they produce. The more interruptions in chest compressions, the worse the victim’s chance of survival from cardiac arrest.* According to the 2005 Guidelines, load-distributing band CPR (LDB-CPR), which the AutoPulse utilizes, “may be considered for use by properly trained personnel as an adjunct to CPR for patients with cardiac arrest in the out-of-hospital or in-hospital setting (Class IIb).”
The AutoPulse—the only device of its kind—delivers the consistent, uninterrupted chest compressions that the new AHA Guidelines are calling for. It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes the entire chest in a consistent, uninterrupted “hands-free” manner, improving blood flow to the heart and brain during cardiac arrest.* Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions.
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation (with ZOLL’s Real CPR Help™ technology), ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation (with ZOLL’s Real CPR Help™ technology), ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East, Asia, and Australia. For more information, visit www.zoll.com or call+1 (978) 421-9655.
Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on August 11, 2006.
©2006 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. Real CPR Help is a trademark of ZOLL Medical Corporation. AutoPulse, LifeBand, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.
*Clinical data available upon request.